Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
HAMILTON, BERMUDA , July 05, 2023 (GLOBE NEWSWIRE) — Heqet will test nanoparticles based on…
HAMILTON, BERMUDA , July 05, 2023 (GLOBE NEWSWIRE) — Heqet will test nanoparticles based on…
Topline data expected in Q3 2023 Carlsbad, CA, July 05, 2023 (GLOBE NEWSWIRE) — Palisade Bio,…
Topline data expected in Q3 2023 Carlsbad, CA, July 05, 2023 (GLOBE NEWSWIRE) — Palisade Bio,…
– Live moderated webcast with members of the GRI Bio, Inc. management team on Tuesday,…
– Live moderated webcast with members of the GRI Bio, Inc. management team on Tuesday,…
Live moderated video webcast on Wednesday, July 12th at 1:00 PM ET EDMONTON, Alberta, July…
Live moderated video webcast on Thursday, July 13th at 10:00 AM ET TORONTO, ONTARIO, July…
Live moderated video webcast on Wednesday, July 12th at 1:00 PM ET EDMONTON, Alberta, July…
Live moderated video webcast on Thursday, July 13th at 10:00 AM ET TORONTO, ONTARIO, July…
Live moderated video webcast on Wednesday, July 12th at 11:00 AM ET OCALA, Fla., July…
Live moderated video webcast on Wednesday, July 12th at 11:00 AM ET OCALA, Fla., July…
• The patent protects additional feature sets of SUPERB’s ultrasound and cooling technology • New patent…
• The patent protects additional feature sets of SUPERB’s ultrasound and cooling technology • New patent…
NEW YORK and LONDON, July 05, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK and LONDON, July 05, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on…